Jazz Pharmaceuticals

Jazz Pharmaceuticals is a biopharmaceutical company headquartered in Dublin, Ireland, and founded in 2003. It develops and commercializes medicines for serious unmet medical needs, with a particular focus on patients with rare diseases and limited or no therapeutic options. The company serves patients in multiple regions worldwide.

Its marketed portfolio covers three therapeutic areas: approved medicines for rare epilepsy indications, approved oncology medicines, and approved treatments for sleep disorders. Alongside these, Jazz maintains a pipeline of investigational therapeutics in clinical research stages. The work spans biopharmaceutical research and development, clinical research, drug manufacturing and technical operations, medical information, patient support, and commercial operations.

The company describes itself as science-driven and patient-focused, connecting research and development with marketed medicines. Its stated purpose is to turn biopharmaceutical discoveries into novel medicines for people with rare diseases, supported by cross-functional collaboration across research and development, commercial operations, and technical operations.

Industry focus areas include biopharmaceuticals, rare diseases, epilepsy and neurology, oncology, and sleep disorders. Further information is available at jazzpharma.com.